Michael A. Carusi
Director · SHOULDER INNOVATIONS, INC.
- 2025
- Aug 5, 2025
- 1
Summary
Latest filing:
Michael A. Carusi is Director of SHOULDER INNOVATIONS, INC. (SI). 1 SEC Form 4 filing on record, dated 5 August 2025. Most recent open-market trade: bought $4.00M of SI on 5 August 2025. Lifetime open-market purchases: $4.00M.
Recent transactions
3The latest 3 SEC Form 4 transactions reported by Michael A. Carusi.
Trading pattern
InsiderAlpha's records for Michael A. Carusi go back to 2025: 1 primary Form 4 filing, an average of 0.5 per year. The typical open-market purchase is $4.00M (1 buy totaling $4.00M). The largest single buy on record is $4.00M of SI in 2025. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Michael A. Carusi files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Gilde Healthcare Holding B.V. - $4.44M in SI purchases and sales in the last 12 months
- Matthew Fraser Ahearn - $839K in SI purchases and sales in the last 12 months
- Robert Joseph Ball - $221K in SI purchases and sales in the last 12 months
- Jeffrey S. Points - $30K in SI purchases and sales in the last 12 months
- Richard Buchholz - $15K in SI purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Michael A. Carusi?
Michael A. Carusi is a corporate insider, tracked as Director of SHOULDER INNOVATIONS, INC. (SI). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Michael A. Carusi last file a Form 4?
The only primary Form 4 on record is dated 5 August 2025.
Has Michael A. Carusi been buying or selling stock?
Recorded transactions: 1 open-market purchase ($4.00M) and 0 open-market sales across all tracked filings.